Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Approach to Reverse and Titrate the Clinical Effects of a Nerve Block

NCT02050295 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02050295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02050295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Approach to Reverse and Titrate the Clinical Effects of a Nerve Block
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2014
Completion date
January 31, 2018
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

regional anesthesia